Cancer patients turning to mass media and non-experts for info

February 24, 2014

PHILADELPHIA (February 24, 2014) - The increasing use of expensive medical imaging procedures in the U.S. like positron emission tomography (PET) scans is being driven, in part, by patient decisions made after obtaining information from lay media and non-experts, and not from health care providers.

That is the result from a three-year-long analysis of survey data, and is published in the article , "Associations between Cancer-Related Information Seeking and Receiving PET Imaging for Routine Cancer Surveillance - An Analysis of Longitudinal Survey Data," appearing in the journal Cancer Epidemiology, Biomarkers & Prevention. Andy S. Tan, Ph.D., a post-doctoral fellow with the University of Pennsylvania's Annenberg School for Communication, is the lead author of the study. Co-authors are Laura Gibson, Ph.D.; Hanna M. Zafar, MD; Stacy W. Gray, MD; Robert C. Hornik, Ph.D.; and Katrina Armstrong, MD.

Data for this analysis were obtained from a longitudinal cohort study comprising three annual mailed surveys between 2006 and 2008 and completed by patients diagnosed with breast, prostate, or colorectal cancers. Over 2,000 individuals participated in the study, funded by the National Cancer Institute.

"Clinical guidelines do not recommend PET for post-treatment surveillance among asymptomatic cancer survivors," explains Dr. Tan and the study's other authors. "Such procedures may result in unnecessary radiation exposure, anxiety, and morbidity associated with false-positive and false-negative results."

The study sought to understand what drives cancer patients to seek such inappropriate procedures, to help inform interventions or policies to stem their overuse. The authors theorized that exposure to cancer-related information may play a role. They suggested that the potential benefit of new medical technologies receives substantial attention in the lay media and may promote positive attitudes toward the role of imaging technology such as PET.

The study looked at two variables: information seeking from non-clinician sources (e.g., TV, radio, books, brochures, newspapers, magazines, the Internet, family members, friends, co-workers, support groups and other non-expert sources) and patient-clinician information engagement (e.g., treating physicians, other physicians or health professionals).

They found that seeking information from nonmedical sources was predictive of subsequent reported PET scan use while patient-clinician information engagement was not. They noted that the overall use of PET scans for routine surveillance seems modest (10-11% of those cancer patients surveyed), however this level of PET overuse may be problematic at the population level because of the large and growing number of cancer survivors.

"Our findings may have important implications for cancer survivors, health care providers, and health policy in the practice of advanced imaging use for routine follow-up," the authors conclude, while raising a follow-up question: Are PET promotional materials used by health care facilities misstating the benefits of PET given that the use of PET imaging for routine cancer surveillance is inconsistent with clinical practice guidelines for most malignancies? "Policies or professional guidelines may be necessary to ensure that health care facilities convey accurate and reliable facts about the appropriate forms of cancer follow-up to patients."
-end-


University of Pennsylvania Annenberg School for Communication

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.